日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110

更正:Alvarado-Miranda 等人,《卡培他滨联合芳香化酶抑制剂作为激素受体阳性、HER2 阴性转移性乳腺癌的一线治疗》,Curr. Oncol. 2023, 30, 6097-6110

Alvarado-Miranda, Alberto; Lara-Medina, Fernando Ulises; Muñoz-Montaño, Wendy R; Zinser-Sierra, Juan W; Galeana, Paula Anel Cabrera; Garza, Cynthia Villarreal; Sanchez Benitez, Daniel; Limón Rodríguez, Jesús Alberto; Arce Salinas, Claudia Haydee; Guijosa, Alberto; Arrieta, Oscar

[Quantification of the burden of chronic kidney disease in Latin America: an invisible epidemicQuantificação da carga da doença renal crônica na América Latina: uma epidemia invisível]

[拉丁美洲慢性肾病负担的量化:一种无形的流行病Quantificação da carga da doença Renica na América Latina: uma Epidemia Invisível]

Rosas-Valdez, Fernando Ulises; Aguirre-Vázquez, Andrea Fernanda; Agudelo-Botero, Marcela

Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

卡培他滨联合芳香化酶抑制剂作为激素受体阳性、HER2阴性转移性乳腺癌的一线治疗方案

Alvarado-Miranda, Alberto; Lara-Medina, Fernando Ulises; Muñoz-Montaño, Wendy R; Zinser-Sierra, Juan W; Galeana, Paula Anel Cabrera; Garza, Cynthia Villarreal; Sanchez Benitez, Daniel; Limón Rodríguez, Jesús Alberto; Arce Salinas, Claudia Haydee; Guijosa, Alberto; Arrieta, Oscar

(68)Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer

(68)Ga-DTPA 抗 HER2 正电子发射断层扫描/CT 可成功预测乳腺癌肺转移灶中人表皮生长因子受体的过表达

Pitalúa-Cortés, Quetzali Gabriela; García-Pérez, Francisco O; Villaseñor-Navarro, Yolanda; Lara-Medina, Fernando Ulises; Matus-Santos, Juan Antonio; Soldevilla-Gallardo, Irma; Porras-Reyes, Fany Iris; Pérez-Sánchez, Victor Manuel; Maldonado-Martínez, Héctor Aquiles; Pérez-Báez, Wendy; Sollozo-Dupont, Isabel